Physician profile
Hailey Russell
NPI 1104587864
$2,885.22
in general payments reported to CMS, 2019-2025
34 companies · $732 in 2025
The $732 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $662 · 2023: $761 · 2024: $730 · 2025: $732.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,222.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $495.31 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $325.79 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $262.94 | 2023-2025 | |
| Abbvie INC. | $172.84 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.67 | 2022-2025 | Jardiance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $158.53 | 2022-2025 | Caplyta |
| Novo Nordisk INC | $141.78 | 2023-2025 | Wegovy |
| Axsome Therapeutics, INC. | $129.49 | 2023-2025 | Auvelity, Sunosi |
| Astrazeneca Pharmaceuticals LP | $118.92 | 2022-2025 | Farxiga, Airsupra |
| Amgen INC. | $106.47 | 2022-2024 | Evenity, Prolia |
| Dynavax Technologies Corporation | $95.73 | 2022-2025 | Heplisav-B |
| Organon LLC | $71.74 | 2022-2025 | Nexplanon |
| Biohaven Pharmaceutical Holding Company LTD. | $70.29 | 2022 | |
| Janssen Pharmaceuticals, INC | $65.97 | 2022-2023 | Xarelto |
| Ironshore Pharmaceuticals INC. | $52.51 | 2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $49.58 | 2023 | Azstarys, Adlarity |
| Inspire Medical Systems, INC. | $47.08 | 2023-2024 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $37.56 | 2022-2023 | Trintellix |
| Otsuka America Pharmaceutical, INC. | $36.26 | 2022-2025 | Rexulti |
| Lundbeck LLC | $34.60 | 2024 | Rexulti |
| Astellas Pharma US INC | $29.20 | 2024-2025 | Veozah |
| Exact Sciences Corporation | $28.73 | 2025 | The Cologuard Plus Collection Kit |
| Biocryst US Sales Co., LLC | $19.72 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $18.75 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.41 | 2025 | |
| Xeris Pharmaceuticals, INC. | $16.22 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $15.37 | 2022 | |
| Dexcom, INC. | $15.36 | 2025 | Dexcom G6 Transmitter |
| Antares Pharma, INC. | $15.16 | 2023 | Tlando, Xyosted, Nocdurna |
| Idorsia Pharmaceuticals US INC | $14.83 | 2022 | |
| Si-Bone, INC. | $14.78 | 2025 | |
| Impel Pharmaceuticals INC. | $13.83 | 2023 | Trudhesa |
| Lucid Diagnostics INC. | $13.45 | 2022 | |
| Phathom Pharmaceuticals, INC. | $8.35 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hailey Russell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.